Aquestive Therapeutics, Inc.
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Nov 9, 2026 (14 days)
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Aug 24, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Nov 7, 2025 | Piper Sandler | maintain | Overweight → Overweight | $8 | 54% |
| Oct 9, 2025 | JMP Securities | maintain | Market Outperform → Market Outperform | $12 | 53% |
| Sep 8, 2025 | Oppenheimer | maintain | Outperform → Outperform | $8 | 52% |
| Jun 17, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $10 | 44% |
| May 15, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $10 | 44% |
| Apr 2, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $10 | 44% |
| Mar 10, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $10 | 44% |
| Mar 7, 2025 | Lake Street | maintain | Buy → Buy | $8 | 47% |
| Dec 20, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $10 | 44% |
| Dec 17, 2024 | Cantor Fitzgerald | initiate | — → Overweight | $17 | 50% |
| Nov 11, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $10 | 44% |
| Nov 6, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $10 | 44% |
| Oct 25, 2024 | Leerink Partners | maintain | Outperform → Outperform | $13 | 51% |
| Oct 25, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $10 | 44% |
| Oct 8, 2024 | JMP Securities | reiterate | Market Outperform → Market Outperform | $9 | 53% |
| Sep 30, 2024 | JMP Securities | reiterate | Market Outperform → Market Outperform | $9 | 53% |
| Sep 30, 2024 | Leerink Partners | reiterate | Outperform → Outperform | $12 | 51% |
| Sep 30, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $10 | 44% |
| Aug 14, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $9 | 44% |
| Aug 12, 2024 | JMP Securities | reiterate | Market Outperform → Market Outperform | $9 | 53% |
| Jul 26, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $9 | 44% |
| Jun 26, 2024 | JMP Securities | reiterate | Market Outperform → Market Outperform | $9 | 53% |
| Jun 5, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $9 | 44% |
| May 10, 2024 | Leerink Partners | initiate | — → Outperform | $8 | 51% |
| May 9, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $9 | 44% |
| Apr 30, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $9 | 44% |
| Apr 11, 2024 | Piper Sandler | initiate | — → Overweight | $10 | 54% |
| Apr 5, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $9 | 44% |
| Mar 28, 2024 | Raymond James | initiate | — → Outperform | $7 | 54% |
| Mar 18, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $9 | 44% |
| Mar 15, 2024 | JMP Securities | maintain | Outperform → Outperform | $10 | 53% |
| Mar 11, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $7 | 44% |
| Mar 7, 2024 | Wedbush | maintain | Outperform → Outperform | $9 | 58% |
| Mar 7, 2024 | Lake Street | maintain | Buy → Buy | $8 | 47% |
| Nov 8, 2023 | HC Wainwright & Co. | maintain | Buy → Buy | $6 | 44% |
| Oct 10, 2023 | Wedbush | reiterate | Outperform → Outperform | $4 | 58% |
| Oct 10, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $5 | 44% |
| Sep 22, 2023 | Wedbush | reiterate | Outperform → Outperform | $4 | 58% |
| Sep 22, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $5 | 44% |
| Sep 21, 2023 | JMP Securities | reiterate | Market Outperform → Market Outperform | $8 | 53% |
| Jul 31, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $5 | 44% |
| Jun 30, 2023 | JMP Securities | reiterate | Market Outperform → Market Outperform | $8 | 53% |
| Jun 21, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $5 | 44% |
| Jun 5, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $5 | 44% |
| Mar 9, 2023 | Wedbush | upgrade | Neutral → Outperform | $4 | 58% |
| Nov 4, 2022 | Alliance Global Partners | maintain | — → Buy | $7 | 41% |
| Sep 7, 2022 | Oppenheimer | initiate | — → Outperform | $8.5 | 52% |
| Sep 6, 2022 | HC Wainwright & Co. | maintain | — → Buy | $5 | 44% |
| Aug 30, 2022 | Alliance Global Partners | initiate | — → Buy | $10 | 41% |
No cross-platform signals in the last 90 days